American Association for Cancer Research

2011-2012 CICR Steering Committee

Stephen Neidle, D.Sc., Ph.D., Chairperson

Professor
University of London School of Pharmacy, London, England
stephen.neidle@pharmacy.ac.uk

Bill W. Day, Ph.D., Chairperson-elect

Professor, Dept. of Pharm. Sciences
Univ. of Pittsburgh School of Pharmacy, Pittsburgh, PA
bday@pitt.edu

Peter C. Dedon, M.D., Ph.D., Past Chairperson

Professor, Division of Bioengineering
Massachusetts Institute of Technology, Cambridge, MA 
pcdedon@mit.edu    

Kent S. Gates, Ph.D. (2009-2012)

Professor, Department of Chemistry
University of Missouri, Columbia, MO
gatesk@missouri.edu 

Susan Nowell Kadlubar, Ph.D. (2010-2012)

Associate Professor, Division of Medical Genetics
University of Arkansas for Medical Sciences, Little Rock, AR
sakadlubar@uams.edu

Stephen A. Munk, Ph.D. (2011-2013)

Chief Executive Officer & President
Ash Stevens, Inc., Detroit, MI
samunk@ashstevens.com

 

Kevin G. Pinney, Ph.D. (2010-2012)

Professor, Department of Chemistry & Biochemistry
Baylor University, Waco, TX
kevin_pinney@baylor.edu 

Thomas E. Smithgall, Ph.D. (2011-2013)

Professor & Chair, Microbiology & Molecular Genetics
University of Pittsburgh School of Medicine
tsmithga@pitt.edu

Melissa M. Vasbinder, Ph.D. (2010-2012)

Principal Scientist
AstraZeneca Pharmaceuticals, Waltham, MA
melissa.vasbinder@astrazeneca.com

Gregory D. Vite, Ph.D. (2011-2013)

Director, Discovery Chemistry
Bristol-Myers Squibb Co., Princeton, NJ
gregory.vite@bms.com

Matthew A. Marx, Ph.D. (2011-2013)

Director, Oncology Chemistry
Takeda Pharmaceutical Company Ltd., San Diego, CA
Matthew.marx@takedasd.com